经皮引流和硬化治疗作为肾淋巴管瘤病的确定性治疗方法。
Percutaneous drainage and sclerotherapy as definitive treatment of renal lymphangiomatosis.
作者信息
Valerio Massimo, Meuwly Jean-Yves, Tawadros Cecile, Jichlinski Patrice
机构信息
Department of Urology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland;
出版信息
Can Urol Assoc J. 2012 Feb;6(1):E3-7. doi: 10.5489/cuaj.11034.
We report the technique and outcome of percutaneous drainage and sclerotherapy as primary treatment of renal lymphangiomatosis. Between January and May 2009, two patients presenting with symptomatic renal lymphangiomatosis were treated in our department by a minimally invasive modality combining percutaneous drainage with repeated sclerotherapy. We retrospectively analysed recurrence, complications and patient satisfaction. In this limited case series, percutaneous drainage and repeated sclerotherapy proved to be safe and effective for treating renal lymphangiomatosis. This procedure provides a minimally invasive option for selected patients, potentially avoiding a surgical procedure and any risk of complications.
我们报告经皮引流和硬化治疗作为肾淋巴管瘤病主要治疗方法的技术及结果。2009年1月至5月期间，我们科室对两名有症状的肾淋巴管瘤病患者采用经皮引流联合重复硬化治疗的微创方式进行了治疗。我们对复发情况、并发症及患者满意度进行了回顾性分析。在这个有限的病例系列中，经皮引流和重复硬化治疗被证明对治疗肾淋巴管瘤病是安全有效的。该 procedure 为选定患者提供了一种微创选择，有可能避免手术及任何并发症风险。
注
原文中“procedure”未明确具体所指，结合前文推测可能是经皮引流联合重复硬化治疗这一过程，但按要求未添加解释。
Zotero 插件